GENNIEFY
Market News
Latest financial news and analysis from global markets
BAC
Investors still skeptical about US dolLar strength amid geopolitical tensions
Investing.com -- A new global survey by Bank of America (BofA) suggests investors remain skeptical about the durability of recent US dollar strength, viewing it as a short-term reaction to geopolitical tensions rather than a lasting trend.
NVDA
The Best Vanguard ETF to Invest $1,000 in This April
With the markets looking very choppy so far in 2026, this sector has the tailwinds to keep moving higher.
INTC
The Best Vanguard ETF to Invest $1,000 in This April
With the markets looking very choppy so far in 2026, this sector has the tailwinds to keep moving higher.
NVDA
Trump Says Palantir Has "Great Warfighting Capabilities," but Michael Burry Thinks It's Overvalued by More Than Half in 2026
Palantir is down more than 35% from its high, and Michael Burry is betting the stock will fall further.
PLTR
Trump Says Palantir Has "Great Warfighting Capabilities," but Michael Burry Thinks It's Overvalued by More Than Half in 2026
Palantir is down more than 35% from its high, and Michael Burry is betting the stock will fall further.
INTC
Trump Says Palantir Has "Great Warfighting Capabilities," but Michael Burry Thinks It's Overvalued by More Than Half in 2026
Palantir is down more than 35% from its high, and Michael Burry is betting the stock will fall further.
INTC
Down More Than 30% This Year, Has Rigetti Computing Stock Bottomed Out?
The stock is down around 75% from its 52-week high.
NVDA
Down More Than 30% This Year, Has Rigetti Computing Stock Bottomed Out?
The stock is down around 75% from its 52-week high.
TSLA
Prolonged Iran War Could Drive Outlook Cuts at US Auto Companies in 2026 Second Half, RBC Says
US automotive companies could lower outlooks in the second half of this year in case of a prolonged
CRSP
CRISPR Therapeutics Touts “Second Phase” After Casgevy, Eyes 6 Data Readouts in 6–12 Months
CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni told investors at the Needham Healthcare Conference that the company is moving into what he described as a “second phase” following the launch of Casgevy, with a broader pipeline spanning cardiovascular, autoimmune disease, oncology, regenerative me
PYPL
PayPal Jumps 5%, Affirm Rockets 6%, SoFi Rises 4% in a Broad Payments and Fintech Rebound
The payments and fintech sector is catching a meaningful bid on Monday, with three of its most actively traded names posting solid gains. PayPal (NASDAQ:PYPL) stock is jumping 6% to $48, Affirm (NASDAQ:AFRM) stock is advancing 7% to $52, and SoFi Technologies (NASDAQ:SOFI) stock is rising 4% to $17. All three names have been among ... PayPal Jumps 5%, Affirm Rockets 6%, SoFi Rises 4% in a Broad Payments and Fintech Rebound
SOFI
PayPal Jumps 5%, Affirm Rockets 6%, SoFi Rises 4% in a Broad Payments and Fintech Rebound
The payments and fintech sector is catching a meaningful bid on Monday, with three of its most actively traded names posting solid gains. PayPal (NASDAQ:PYPL) stock is jumping 6% to $48, Affirm (NASDAQ:AFRM) stock is advancing 7% to $52, and SoFi Technologies (NASDAQ:SOFI) stock is rising 4% to $17. All three names have been among ... PayPal Jumps 5%, Affirm Rockets 6%, SoFi Rises 4% in a Broad Payments and Fintech Rebound